Methods peR primers for highly polymorphic sites within the EDNl and NOS3 genes were used to genotype individuals with type 1 or type 2 diabetes with severe or no retinopathy.
There is strong evidence that the earliest pathological changes in diabetic vascular disease are involved with vascular endothelial dysfunction?-4 A variety of molecules with potent vasoactive functions are produced and released by the vascular endothelium. The two major classes of agents with potent effects on the vasculature include the nitric oxide synthases, which mediate vasodilation, and the .
5 In endothelins, which are vasoconstnctors. clinical and experimental diabetes both vasodilator and vasoconstrictor responses are aberrant early in the disease, suggesting that changes in blood flow may contribute to diabetic microangiopathy.6,7 The retinal circulation is devoid of any extrinsic enervation, and is dependent entirely on endothelium mediated autoregulation;8 thus endothelial dysfunction in diabetes is likely to have a major impact on the circulation within the retina. At the cellular level the factors that initiate and promote the development of diabetic retinopathy include duration of diabetes, poor glycaemic control and the concomitant presence of hypertension and hyperlipidaemia.9 Clinical trials10 and family studies indicate that in addition to environmental influences, genetic factors may also affect the onset or severity of , diabetic retinopathyY·1 2 The published evidence indicates that specific genes may contribute to susceptibility or resistance to diabetic retinopathy.
Exposure of retinal vascular endothelial cells to high ambient glucose causes a downregulation of constitutive endothelial nitric oxide synthase (NOS3) expression. 1 3 Targeted disruption of the endothelin-l (EDN1) 14 and NOS3 15 genes in mice confer aberrant cardiovascular phenotypes. Huang et al. 16 also used genetic experiments to show that NOS3 appeared to be directly involved with hypertension. Evidence thus suggests that EDNl and NOS3 genes may be directly involved in microvascular disorders including diabetic retinopathy. We chose to study the polymorphic variability in the genes encoding the proteins ET-1 (EDN1) and cNOS (NOS3) in two groups of diabetic patients, one with severe retinopathy, the other with no retinopathy.
Materials and methods

Clinical assessment
Institutional ethical approval was obtained at both study centres (Northern Ireland and Liverpool area) for this project. Individuals with diabetes mellitus were recruited after giving informed consent. Patients recruited into the study fell into two categories. The first category consisted of individuals with no retinopathy in either eye (5 microaneurysms or fewer) and, if type 1 diabetics, the duration of disease had to be 15 years or more from diagnosis. The second category consisted of individuals with severe retinopathy (level 50 or worse) in either eye. Fundi were examined using slit-lamp biomicroscopy and graded for retinopathy by experienced ophthalmologists based on the ETDRS (Early Treatment Diabetic Retinopathy Study) modification of the Airlie House classificationY Patients with intermediate grades of retinopathy (levels 20-50) and/or maculopathy alone were excluded to maximise separation of the two groups selected for study.
The following clinical data were collected: age and sex, type, duration and family history of diabetes, presence of vascular disease (angina, hypertension, peripheral vascular disease), renal function (dipstick microalbuminuria, albumin/ creatinine ratio) and glycaemic control (biannual HbAle readings were obtained over the preceding 3 years for 85% of patients).
Type 1 diabetes was defined as diabetes diagnosed before 30 years of age or evidence of absolute insulin dependence (e.g. an episode of ketoacidosis). All other cases were deemed to be type 2 diabetes. The data presented herein represent 211 patients from Northern Ireland and 127 patients from Liverpool.
DNA extraction and peR
Standard methods were used for blood collection, DNA extraction and the polymerase chain reaction (PCR). PCR primers and the conditions for amplification have been described previously for both markers: EDNl l8 and NOS3. l9 The EDNl marker is a dinucleotide repeat located in the 5'-untranslated region of the endothelin-1 gene with 11 reported alleles (197-217 bp; we designated the largest fragment AI) and a heterozygosity of 0.78.
The NOS3 marker is a dinucleotide repeat located within intron 13 and 23 reported alleles (134-190 bp; the 134 bp fragment is 'AI') with heterozygosity of 0.92. Published allele frequencies for EDN1 18 and NOS3 19 markers are available for Northern European Caucasians. We have typed 91 and 66 random anonymous adults for these markers, respectively, in Northern Ireland in order to compare frequencies in the general population with those in diabetes patients, as shown in Table 1 .
Statistical methods
It was planned to recruit 75 patients with retinopathy and 75 patients without retinopathy for the Northern Ireland study. This was sufficient to give the study in excess of 80% power to detect as statistically significant (p < 0.05 with Bonferroni correction for up to 20 comparisons) a difference in the frequency of an allele between groups of 10% versus 30%. A similar number of samples were collected from Liverpool. Allele frequencies There is no association between any allele of EDNl and
Retinopathy or No Retinopathy in Liverpool
The data for patients recruited from Liverpool are shown in Table 2 The distribution of alleles of the NOS3 marker did not differ significantly between the Retinopathy and No Retinopathy patients in Northern Ireland (Table 3) . When the data were compared with the population frequencies reported for Northern Europe there were also no significant differences. There were also no significant differences in the distribution of alleles in Retinopathy 22 It is interesting to note that the endothelins are implicated in a number of vascular diseases including the pathology of retinopathy, 23 so perhaps it was disappointing not to see a more direct involvement of a marker of the EDNl gene. Where mutant mice have been studied, modification in the endothelin components has had critical effects on the development of the cardiovascular system and other tissues.14, 2 4, 2 5 In the present study the distribution of the EDNl alleles was not statistically significant between groups of diabetic patients with and without retinopathy in both Northern Ireland and Liverpool. However, one of the rarer alleles was less commonly encountered in patients with retinopathy in both sample populations. It is possible that minor contributions from this gene may influence an individual's susceptibility to retinopathy, but the study had insufficient power to detect this association. As other genes of the endothelin and nitric oxide synthase signal transduction pathway may be relevant to the pathogenesis of diabetic retinopathy these studies have not ruled out genetic contributions from these families of genes to this disease.
